Top Abstract Purchase Related
Home
>
Node
>
Subnode

Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines

Mehta, S.R.

Journal of Invasive Cardiology 14 Suppl E: 27e-34e; Quiz 35e

2002

ISSN/ISBN: 1042-3931
PMID: 12668860
Document Number: 551287
Thrombosis is the most important pathological mechanism of acute coronary syndromes (ACS). In addition to standard antithrombotic treatment with aspirin and heparin, clopidogrel, glycoprotein IIb/IIIa inhibitors, and low-molecular-weight have a therapeutic benefit in ACS patients. Updated American College of Cardiology/American Heart Association guidelines for the management of ACS patients were published in mid-2002, and this article summarizes the rationale for the recommendations outlined in these guidelines for the use of antithrombotic and antiplatelet therapies.

Document emailed within 1 workday
Secure & encrypted payments

Guthrie, R.M. 2015: The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromes Journal of Family Practice 64(12 Suppl)
Fake, A.; Ranchord, A.; Harding, S.; Larsen, P. 2017: Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review Current Cardiology Reviews 13(4): 325-333
Clem, J.R.; Falls, S. 1998: Advances in antiplatelet therapy for acute coronary syndromes South Dakota Journal of Medicine 51(7): 233-234
Cohen, M.; Diez, J.E.; Levine, G.N.; Ferguson, J.J.; Morrow, D.A.; Rao, S.V.; Zidar, J.P. 2007: Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III Journal of invasive cardiology 19(12): 525
Xu, J.J.; Tang, X.F.; Song, Y.; Xu, N.; Yao, Y.; Wu, Y.; Zhang, J.; Gao, Z.; Chen, J.; Gao, R.L.; Yang, Y.J.; Yuan, J.Q. 2017: Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 45(2): 116-120
Chazov, E.I.; Panchenko, E.P. 2000: Antithrombotic therapy in acute coronary syndrome Terapevticheskii Arkhiv 72(3): 65-75
Timóteo, A.T.; Fiarresga, A.ón.; Feliciano, J.; Pelicano, N.; Ferreira, L.; Oliveira, J.é A.; Serra, J.é; Ferreira, R.; Quininha, J. 2006: Impact of combination medical therapy on mortality in patients with acute coronary syndromes Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 25(12): 1109-1118
Hamer, A.; Kerr, A.; Wong, B.; Renner, C.; Wong, C-Kit.; Ellis, C.; Nunn, C.; Smyth, D.; Devlin, G.; Wilkins, G.; Armstrong, G.; Hart, H.; White, H.; Patel, H.; Crozier, I.; Ternouth, I.; Elliott, J.; Belz, L.; Abernathy, M.; Simmonds, M.; Webster, M.; Williams, M.; Harrison, N.; Tanser, P.; Matsis, P.; Stewart, R.; Luke, R.; Harding, S.; El-Jack, S.; Mann, S. 2012: New Zealand 2012 guidelines for the management of non ST-elevation acute coronary syndromes New Zealand Medical Journal 125(1357): 122-147
Zhunussov, Y.; Taizhanova, D.; Abdullabekova, R.; Bitz, U.; Visternichan, O. 2016: Optimum Application of Modern Antithrombotic Drugs among Patients with the Acute Coronary Syndrome with the Risk of Stricture Formation of Coronary Arteries Georgian Medical News 251: 40-45
Oomman, A.; Ramachandran, P.; Shanmugapriya; Subramanian, P.; Nagaraj, B.M.S. 2003: A novel trigger for acute coronary syndromes: the effect of lunar cycles on the incidence and in-hospital prognosis of acute coronary syndromes--a 3-year retrospective study Journal of the Indian Medical Association 101(4): 227-228
Jedsadayanmata, A. 2013: Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation Journal of the Medical Association of Thailand 96(1): 91-98
Hinneburg, I. 2011: Ticagrelor: a novel antiplatelet agent for patients with acute coronary syndrome Medizinische Monatsschrift für Pharmazeuten 34(7): 226-232
Guha, S.; Sardar, P.; Guha, P.; Roy, S.; Mookerjee, S.; Chakrabarti, P.; Deb, P.K.; Chaudhuri, U.; Deb, S.; Karmakar, R.; Dasgupta, A.K.; Lahiri, P. 2009: Dual antiplatelet drug resistance in patients with acute coronary syndrome Indian Heart Journal 61(1): 68-73
Boden, W.E. 2003: Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies Minerva Cardioangiologica 51(5): 447-461
Bozzani, A.; Ferlini, M.; Rossini, R.; Musumeci, G.; Arici, V.; Bramucci, E.; Setacci, C. 2015: Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery Journal of Cardiovascular Surgery 56(4): 681-683
Fu, Y.; Li, K.; Yang, X. 2015: Safety of percutaneous coronary intervention in patients with acute coronary syndromes complicating chronic kidney disease Zhonghua Xin Xue Guan Bing Za Zhi 43(10): 848-853
Kerr, A.J.; Lin, A.; Lee, M.; Ternouth, I.; Killion, B.; Devlin, G. 2013: Risk stratification and timing of coronary angiography in acute coronary syndromes: are we targeting the right patients in a timely manner? (ANZACS-Qi 1) New Zealand Medical Journal 126(1387): 69-80
Jibran, R.; Khan, J.A.; Hoye, A. 2010: Gender disparity in patients undergoing percutaneous coronary intervention for acute coronary syndromes - does it still exist in contemporary practice? Annals of the Academy of Medicine Singapore 39(3): 173-178
Niemelä, K.; Vikman, S.; Tierala, I.; Airaksinen, J. 2003: New challenges in diagnostics and therapy of acute coronary syndromes Duodecim; Laaketieteellinen Aikakauskirja 119(5): 369-371
Langer, A.; Constance, C.; Fodor, J.G.; Frohlich, J.J.; Grégoire, J.; Lau, D.C.W.; Leiter, L.A.; Mancini, G.B.John.; Marr, D.; McPherson, R.; O'Neill, B.J.; Rabkin, S.W. 2003: Statin therapy and the management of acute coronary syndromes Canadian Journal of Cardiology 19(8): 921-927